Company news
MDxHealth SA news in 2024
MDxHealth SA's news releases, calls and decks from 2024, newest first.
MDxHealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2024
November 5, 2024
Underwriting Agreement Form 6 K
October 29, 2024
MDxHealth to Present Third Quarter 2024 Financial Results and Corporate Update on November 6
October 13, 2024
SECURITIES PURCHASE AGREEMENT Form 6 K
September 30, 2024
MDxHealth Announces Pricing of Offering of Ordinary Shares
September 24, 2024
MDxHealth Announces Launch of Offering of Ordinary Shares
September 24, 2024
MDxHealth Reports Q2 and Half Year 2024 Results
August 20, 2024
MDxHealth to Present Second Quarter and First Half 2024 Financial Results and Corporate Update on August 21
August 11, 2024
MDxHealth Reports Preliminary Q2 and Half Year 2024 Revenues and Raises 2024 Revenue Guidance
July 7, 2024
Mdxhealth Appoints Sanford J. Siegel, M.D. to Board of Directors
July 7, 2024
REGISTRATION RIGHTS AGREEMENT Form 6 K
June 20, 2024
Extraordinary GENERAL MEETING Form 6 K
June 5, 2024
CEO PURCHASES SHARES OF MDXHEALTH - Form 6-K
May 6, 2024
MDxHealth Reports Q1-2024 Results and Announces Growth Capital from OrbiMed
April 30, 2024
Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering
March 11, 2024
Mdxhealth Announces Fourth Quarter and Full-Year 2023 Financial Results
March 5, 2024
MDxHealth to Present Fourth Quarter and Full Year 2023 Financial Results and Corporate Update on March 6
February 20, 2024